- Fulvestrant, sold
under the
brand name
Faslodex among others, is an
antiestrogenic medication used to
treat hormone receptor (HR)-positive
metastatic breast...
- (INN)
faropenem medoxomil (USAN)
fasidotril (INN)
fasiplon (INN)
Faslodex Faslodex (IPR)
fasobegron (INN)
fasoracetam (INN)
Fastin fasudil (INN) favipiravir...
- first-in-class medication. Capivasertib, used in
combination with
fulvestrant (
Faslodex), is
indicated for
adults with
hormone receptor-positive,
human epidermal...
-
Antihormone therapy is a type of
hormone therapy that
suppresses selected hormones or
their effects, in
contrast with
hormone replacement therapy, which...
- therapy. As of 2016 the only
marketed SERD was
fulvestrant (brand name
Faslodex). As of
November 2016
other SERDs under development include brilanestrant...
-
developing breast cancer.
Another chemotherapeutic anti-estrogen, ICI 182,780 (
Faslodex),
which acts as a
complete antagonist, also
promotes degradation of the...
- for "Phase I
Study of
Combination of
Gedatolisib With
Palbociclib and
Faslodex in
Patients With ER+/HER2-
Breast Cancer" at ClinicalTrials.gov This article...
- (ICR) and
Cancer Research Technology Limited).
Truqap in
combination with
Faslodex received approval from the US FDA in 2023 for the
treatment of
adult patients...
- factor-kappaB, and
cyclic AMP
response element binding with
acquired resistance to
Faslodex (ICI 182,780)".
Cancer Research. 62 (12): 3428–3437. PMID 12067985. Wärri...
